NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News $62.61 +2.20 (+3.64%) Closing price 03:59 PM EasternExtended Trading$62.64 +0.04 (+0.06%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABU alerts:Sign Up Key Stats Today's Range$60.69▼$64.0550-Day Range$37.64▼$61.6452-Week Range$32.55▼$152.60Volume1.53 million shsAverage Volume1.48 million shsMarket Capitalization$683.70 millionAssets Under Management$600.35 millionDividend Yield0.42%Net Expense Ratio0.96%Aggregate RatingModerate Buy ETF OverviewThe Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More… Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.57%0.57%0.52%0.53%Other Expenses0.21%0.30%0.48%0.56%0.51%Total Expense0.96%0.70%0.72%0.73%0.71%Fee Waiver0.00%-0.45%-0.49%-0.65%-0.54%Net Expense0.96%0.61%0.63%0.58%0.60% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABU ETF News HeadlinesDirexion Daily S&P Biotech Bull 3X Shares (LABU) After-HoursJune 5, 2025 | nasdaq.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.10714March 25, 2025 | msn.comWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsJune 10, 2025 | True Market Insiders (Ad)Direxion Daily Semiconductor Bear 3X Shares rises 11.6%March 6, 2025 | markets.businessinsider.comULTY: ~74% Trailing Yield, But Look Out BelowOctober 11, 2024 | seekingalpha.comDirexion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.3367September 24, 2024 | msn.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $90.00 at the beginning of 2025. Since then, LABU stock has decreased by 29.6% and is now trading at $63.3550. View the best growth stocks for 2025 here. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Shares of Direxion Daily S&P Biotech Bull 3x Shares reverse split before market open on Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Top institutional investors of Direxion Daily S&P Biotech Bull 3x Shares include Jane Street Group LLC, Ethos Financial Group LLC (0.06%), XTX Topco Ltd (0.05%) and McGuire Investment Group LLC (0.04%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings142 Fund Statistics Assets Under Management$624.79 million Average Daily Volume$2.53 million Discount/Premium-0.10% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume10,614 Put Options3,554 Call Options7,060 Short Interest2,010,000 shs Miscellaneous Outstanding Shares10,920,000Beta2.54 Creation Unit50,000 Creation Fee$250.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 10 LABU HoldingsGoldman Sachs Sterling FixInc Port IncHolding Weight: 18.13%Dreyfus Govt Cash Man InsHolding Weight: 16.11%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 8.47%Dreyfus Trsry Securities Cash MgmtHolding Weight: 6.03%S&P Biotechnology Select Industry Index SwapHolding Weight: 3.55%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 2.38%Exact Sciences (NASDAQ:EXAS)Holding Weight: 2.31%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 2.14%Natera (NASDAQ:NTRA)Holding Weight: 2.07%United Therapeutics (NASDAQ:UTHR)Holding Weight: 1.97%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.